This expanded partnership helps Evonik to streamline its distribution model in Asia Pacific
This innovative formulation combines cutting-edge ingredients is a first of its kind in India to have a Duo-Lipo technology
The new facility, which has a capacity of 5,000 metric tonnes, will manufacture nutraceuticals and dietary-active ingredients for human consumption.
The revenue from operations in Q3 FY25 is Rs. 8,358.6 crore, up 16% YoY
Increases speed to market for drug developers working on nucleic acid therapeutics
These three NDAs of Sitagliptin (base) and combination franchise have been approved by the USFDA earlier through the 505(b)(2) route
The centre features a cutting-edge climatic chamber for stability testing and spectrophotometry to ensure that products meet the most stringent manufacturing and testing standards
The GMP certificate will allow the manufacturing site in Hervás, Cáceres to manufacture active ingredients for the pharmaceutical industry that is based on medicinal plants
Wacker Biotech will manufacture the active ingredients of MinervaX’s novel vaccine candidate
This existing GMP compliant facility, located at Bharuch (Unit-1) with ongoing expansion part of the company's strategic capex initiative
Subscribe To Our Newsletter & Stay Updated
